LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on October 28, 2026

Oct. 28, 2026

'All That' Star Angelique Bates Continues 'Queen of the Red Carpet' Run At Successful RUSH Halloween Party & Screening

Indeterminate EIN Presswire

Oct. 28, 2026

Brazilian LegalTech Macohin Advances Autonomous AI With Elza A.I.

Indeterminate EIN Presswire

Oct. 28, 2026

Velaris Markets launches dual brokerage and prop trading model under one brand

Indeterminate GlobeNewswire

Oct. 28, 2026

inCruises extiende su racha ganadora de Premios Magellan con dos reconocimientos en 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

inCruises、2026年に2つの受賞により、Magellan賞の連続受賞記録を更新

Indeterminate GlobeNewswire

Oct. 28, 2026

Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine

Indeterminate GlobeNewswire

Oct. 28, 2026

Nacuity Pharmaceuticals Announces First Patient Dosed in Global Confirmatory Phase 3 Trial of NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome

Indeterminate GlobeNewswire

Oct. 28, 2026

Critical Metals Corp. Confirms Option Scheme Consideration for European Lithium Acquisition

Indeterminate GlobeNewswire

Oct. 28, 2026

Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery

Indeterminate GlobeNewswire

Oct. 28, 2026

FEMSA Anuncia Resultados del Tercer Trimestre 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

FEMSA Announces Third Quarter 2026 Results

Indeterminate GlobeNewswire

Oct. 28, 2026

SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia

Indeterminate GlobeNewswire

Oct. 28, 2026

Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis

Indeterminate GlobeNewswire

Oct. 28, 2026

Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign

Indeterminate GlobeNewswire

Oct. 28, 2026

RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

Oct. 28, 2026

Jamaica’s “Together We Rise” Monument Sends a Message of Resilience and Gratitude to the World

Indeterminate GlobeNewswire

Oct. 28, 2026

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

ORYZON to participate in upcoming events in November

Indeterminate GlobeNewswire

Oct. 28, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 

Indeterminate GlobeNewswire